Entos Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Entos develops next-generation genetic medicines using their proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.
Entos Pharmaceuticals has raised $5.1M across 4 funding rounds on record, the most recent an undisclosed round announced in Jan 2026.
Entos Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Entos Pharmaceuticals Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
Entos Pharmaceuticals raised $100k in an undisclosed round announced in Jan 2024.
1.1 years later, an undisclosed round of $4.0M was announced in Feb 2025.
3 months later, an undisclosed round of $1.0M was announced in May 2025.
8 months later, an undisclosed round was announced in Jan 2026 with no disclosed amount.
Entos Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Entos Pharmaceuticals Funding Compared to Other Biotechnology Startups
Funded Startups Like Entos Pharmaceuticals in Biotechnology and Edmonton
Companies Similar to Entos Pharmaceuticals
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Entos Pharmaceuticals Funding FAQs
What does Entos Pharmaceuticals do?
Entos develops next-generation genetic medicines using their proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.
How much funding has Entos Pharmaceuticals raised?
Entos Pharmaceuticals has raised $5.1M across 4 rounds on record.
When did Entos Pharmaceuticals last raise funding?
Entos Pharmaceuticals' most recent funding round on record was announced in Jan 2026. The amount was not disclosed.
Who founded Entos Pharmaceuticals?
FundedIQ lists Andries Zijlstra (Founder), Roy Duncan (Founder) at Entos Pharmaceuticals.
Where is Entos Pharmaceuticals headquartered?
Entos Pharmaceuticals is based in Edmonton, Alberta, Canada.
How many employees does Entos Pharmaceuticals have?
Entos Pharmaceuticals is in the 11-50 employee band.
About FundedIQ's Entos Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Entos Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.